Searched for
STERILE LIQUID PHARMACEUTICALS
War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Centre in talks with Assam Petrochemicals, others to secure methanol supply for pharma amid West Asia disruptionsIndia is working to secure methanol for its pharmaceutical sector. Global supply chains are facing disruptions due to the West Asia crisis....
- Centre looks to trigger 'Essentials' Act to regulate prices of bulk drugsDrug prices in India: The department of pharmaceuticals (DoP) has been holding meetings with industry executives to take stock of the situa...
- Amanta Healthcare shares list at 7% premium over IPO priceAmanta Healthcare shares: Amanta Healthcare shares debuted with a premium, listing at Rs 135 on NSE and Rs 134 on BSE against an issue pric...
- Amanta Healthcare IPO subscribed nearly 83 times at close; GMP at 8%. Should you bid?Amanta Healthcare’s Rs 126 crore IPO was subscribed nearly 83 times at close, driven by NIIs and RIIs. Trading at an 8% GMP, the stock may ...
- Amanta Healthcare IPO subscribed 12.40 times on Day 2; GMP at 12% — Should you bid? Check key detailsAmanta Healthcare's Rs 126 crore IPO witnessed strong investor demand, subscribing 12.40 times on its second day, driven by retail investor...
- Amanta Healthcare IPO subscribed 3.2 times so far on Day 1; GMP at 15%. Should you bid?Amanta Healthcare's IPO witnessed strong investor demand, being oversubscribed 3.2 times on its opening day, driven by retail and non-insti...
- Amanta Healthcare IPO opens for subscription; GMP at 22%. Should you bid?IPO GMP: Amanta Healthcare's Rs 126 crore IPO opened on Monday, with a price band of Rs 120-126 per share. The Ahmedabad-based pharma compa...
- Dishman Carbogen Amcis opens $50 million new facility in FranceBuilt on newly acquired land located 7km from an existing CARBOGEN AMCIS site in Riom, the new facility increases product development and m...
- Gland Pharma falls 5% after announcing Cenexi Group acquisitionCenexi, along with its subsidiaries, is engaged primarily in the business of Contract Development & Manufacturing Organisation (CDMO) of ph...
- Gland Pharma acquires French CDMO Cenexi for €120 millionFounded in 2004, Cenexi, along with its subsidiaries, is engaged primarily in the business of CDMO of pharmaceutical products with expertis...
- Jubilant Life Sciences raises Rs 495 cr via securitiesShares of Jubilant Life Sciences today ended at Rs 702.55per scrip on the BSE, down 0.95 per cent from previous close.
- Jubilant Life Sciences to raise Rs 2,000 crore through non-convertible debenturesThe company added that the borrowing through debentures will be within the above overall borrowing limit of Rs 5,000 crore.
- Jubilant Life to hike Niacin prices by 18%Drug-maker Jubilant Life Sciences today announced a price increase of 18 per cent for Niacin feed-grade, with immediate effect.
- Mylan’s Agila Specialties deal faces riders from US watchdogUS-based generic giant Mylan Inc’s $1.85-billion bid to acquire Indian drugmaker Agila Specialties now faces fresh riders, this time from i...
- Jubilant Life to split pharmaceutical business into two subsidiariesJubilant Life Sciences is splitting its pharmaceutical business into two subsidiaries with drug development set to become a separate entity.
- Jubilant inks $70 mn manufacturing pact with US firmJubilant Life Sciences today said its has signed a contract manufacturing agreement with an undisclosed US pharmaceutical firm to produce a...
- Pharma cos inject capacities to meet growing demandIndian pharmaceutical companies with a presence in sterile injectables space are expanding capacities to cater to growing demand in this se...
- Marksans Pharma buys UK based Hale GroupMarksans Pharma has acquired UK based pharma company Hale Group for an undisclosed amount.
Load More
